Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-31

Clinical Trial Update: Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing autologous CD34+ stem cell injections for severe intermittent claudication in peripheral artery disease; current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous CD34+ Stem Cell Injection (CD34+ stem cell therapy)

Snippet

Sponsor: Losordo, Douglas, M.D. | Conditions: Peripheral Artery Disease, Severe Intermittent Claudication | Phase 1 | Status: UNKNOWN